Although our results need confirmation in further studies, they show that a simple algorithm combining age, education, as well as serum GDNF and imaging parameters can classify cognitive status, in the appropriate clinical context, clinicians and researchers can use the proposed method to evaluate the degree of cognition objectively and calculate risk of cognitive decline for individuals with early Parkinson's disease. The gene discussed is GDNF; the disease is Mental deterioration.